E
Diagnos Inc. ADK.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -7.51% -15.96% -42.72% 12.70% -0.76%
Total Depreciation and Amortization -6.81% -0.42% 1.72% -1.28% -10.98%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -44.77% 41.53% 1.31% -8.82% 1.21%
Change in Net Operating Assets 53.35% -162.13% 204.95% -478.43% 197.64%
Cash from Operations -10.83% -97.14% 29.21% -45.19% 19.74%
Capital Expenditure 43.33% 42.31% -- -- -7.69%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 54.35% 51.50% -200.99% -350.27% 98.64%
Cash from Investing 54.29% 51.46% -202.41% -352.70% 100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -519.48% -11.38% 5.26% 0.00% -5.84%
Issuance of Common Stock 25.57% -38.76% 93.42% 135.73% -13.51%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 19.33% -0.94% 1.72% -3.28% 7.81%
Cash from Financing 10.53% -42.30% 103.48% 166.32% -15.04%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 104.22% -215.96% 536.70% -170.38% 436.25%